BackMEDIROM Healthcare Technologies Overview

MEDIROM Healthcare Technologies Operating Income

Latest operating income for MRM: $47M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$70.63M
88.58% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$46.88M
2128.31% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

MEDIROM Healthcare Technologies (MRM) FAQ

MEDIROM Healthcare Technologies (MRM) currently reports a operating income of $47M as of December 2025. That compares with $-2.3M in the prior-year period — up 2128.3% year over year. Use the charts on this page to explore MEDIROM Healthcare Technologies's operating income history and peer comparisons.

MEDIROM Healthcare Technologies's operating income increased from $-2.3M to $47M — a 2128.3% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MEDIROM Healthcare Technologies reported $47M in operating income as of December 2025. That compares with $-2.3M in the prior-year period — up 2128.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $47M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MEDIROM Healthcare Technologies, and consider following MRM for alerts when major investors trade the stock.

MEDIROM Healthcare Technologies is classified in the Consumer Discretionary sector. On operating income, it currently shows $47M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Discretionary are usually more informative than comparing MRM with unrelated industries.